Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Radical Pleurectomy/decortication And Intraoperative Radiotherapy Followed By Conformal Radiation With Or Without Chemotherapy For Malignant Pleural Mesothelioma.

T. T. Lee, Darcie L. Everett, H. Shu, T. Jahan, M. Roach, J. Speight, R. Cameron, T. Phillips, A. Chan, D. Jablons
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
OBJECTIVES We performed a retrospective review of the efficacy and morbidity of radical pleurectomy/decortication and intraoperative radiotherapy followed by external beam radiation therapy with or without chemotherapy for diffuse malignant pleural mesothelioma. METHODS A total of 32 patients with diffuse malignant pleural mesothelioma were initially evaluated between January 1995 and September 2000. Three patients were excluded from analysis because of unresectable disease. Two patients died postoperatively, and one patient had recurrent disease previously treated at an outside institution. Of the remaining 26 patients included in the analysis, 24 received intraoperative radiotherapy. External beam radiation therapy was generally started 1 to 2 months after resection and delivered by means of 3-dimensional conformal radiation therapy or with inverse treatment planning intensity-modulated radiation therapy. When given, chemotherapy consisted of 2 to 3 cycles of cyclophosphamide, doxorubicin (Adriamycin), and cisplatin initiated 1 to 2 months after completion of radiation. RESULTS At the time of data analysis, 5 of 26 patients were alive. The median follow-up was 9.7 months (range, 2-67.6 months). The median overall survival and progression-free interval from the time of the operation were 18.1 and 12.2 months, respectively. The Kaplan-Meier estimates of overall survival and freedom from progression at 1 year were 64% and 50%, respectively. The site of failure was mostly locoregional. However, there were 4 abdominal failures and 1 contralateral lung failure. CONCLUSIONS Radical pleurectomy/decortication with aggressive radiotherapy with or without chemotherapy might offer an alternative treatment option to those who cannot tolerate extrapleural pneumonectomy.

This paper is referenced by
What is the role of radiotherapy in malignant pleural mesothelioma?
A. Price (2011)
Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma
S. Hasegawa (2014)
Malignant Pleural Mesothelioma: A Population-Based Study of Survival
M. Milano (2010)
Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center
R. Flores (2007)
BTS statement on malignant mesothelioma in the UK, 2007
Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients
P. Bovolato (2014)
May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?
T. Mineo (2010)
Pleurectomy/decortication versus extrapleural pneumonectomy: a critical choice.
P. Filosso (2018)
Role of new radiation techniques in the treatment of pleural mesothelioma
M. Amichetti (2013)
Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma
G. Marulli (2017)
Four-Modality Therapy in Malignant Pleural Mesothelioma: A Phase II Study
M. Lucchi (2007)
Malignant pleural mesothelioma: a comprehensive review.
R. Ismail-Khan (2006)
Racial Disparities in Treatment Patterns and Survival Among Surgically Treated Malignant Pleural Mesothelioma Patients
N. Alpert (2020)
Kinetics of Host Cell Recruitment During Dissemination of Diffuse Malignant Peritoneal Mesothelioma
N. Miselis (2010)
Progress in Radical Surgery for Malignant Pleural Mesothelioma
L. Politi (2013)
Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined-Modality Treatment of Malignant Pleural Mesothelioma
A. Chi (2011)
Imaging characteristics of pleural tumours
L. De Paoli (2015)
Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma
L. Lang-Lazdunski (2011)
Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma
D. Sterman (2005)
Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis
Z. Zhao (2017)
Malignant Pleural Mesothelioma—An Update
D. Stewart (2004)
Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population
R. Flores (2010)
Treatment of Malignant Pleural Mesothelioma with Carboplatin, Liposomized Doxorubicin, and Gemcitabine: A Phase II Study
G. Hillerdal (2008)
Semantic Scholar Logo Some data provided by SemanticScholar